Medical Devices: Page 6
-
Medtronic, GE HealthCare expand patient monitoring alliance
Expanding the long-running partnership will bring Medtronic technologies, such as the Nellcor pulse oximetry product, to more healthcare settings.
By Nick Paul Taylor • March 4, 2026 -
Retrieved from Fresenius Kabi on March 03, 2026
Fresenius Kabi recalls Ivenix infusion pumps over software problem
Fresenius has issued a software release to address issues that could interrupt treatment with its Ivenix large volume pumps.
By Elise Reuter • March 3, 2026 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Boston Scientific gets Farapulse label expansion in Europe
With CE mark approval, the pulsed field ablation procedure becomes available to treat patients in Europe with persistent atrial fibrillation.
By Susan Kelly • March 3, 2026 -
FDA warns insulin infusion set maker Unomedical over leaks, mishandled complaints
Unomedical, which supplies diabetes tech firms including Medtronic, Tandem Diabetes Care and Beta Bionics, received more than 5,000 complaints about leaking infusion sets between 2023 and 2025.
By Elise Reuter • March 2, 2026 -
Abbott wins FDA approval for updated heart failure monitoring device
The company redesigned the reader to fit in a carry-on suitcase and be easier to use day to day.
By Nick Paul Taylor • March 2, 2026 -
Trump administration targets DME suppliers in fraud crackdown
The government plans a six-month moratorium on supplier enrollment in the Medicare program to find ways to stop what it called “longstanding instances of fraud, waste, and abuse” by certain companies.
By Susan Kelly • Feb. 27, 2026 -
UFP Technologies investigating cyberattack that impacted company data
The medical device maker warned of short-term shipment delays, but does not see a material impact.
By David Jones • Feb. 27, 2026 -
GE HealthCare forms 10-year imaging alliance with UCSF Health
The partnership covers the implementation of remote scanning and workforce development.
By Nick Paul Taylor • Feb. 27, 2026 -
Medtech M&A starts off strong in 2026
The latest deals include Stryker’s purchase of Amplitude Vascular Systems and Roche’s plans to buy PathAI for up to $1.05 billion.
By Elise Reuter • Updated May 14, 2026 -
FDA warns Beta Bionics on unreported complaints, insulin pump changes
The Food and Drug Administration warning letter detailed unreported low blood sugar and a software change to correct for delayed glucose readings.
By Elise Reuter • Feb. 26, 2026 -
FDA posts early alert for safety issue with Impella heart pump devices
The cassettes have an increased risk of purge leaks that can lead to the loss of hemodynamic support.
By Nick Paul Taylor • Feb. 26, 2026 -
Quantum Surgical buys J&J’s NeuWave
Quantum, developer of the Epione robotic platform for cancer treatment, said the acquisition supports its strategy of reducing cancer mortality through robot-assisted tumor ablation.
By Susan Kelly • Feb. 25, 2026 -
AdvaMed names Jake Leach as chair of diabetes sector
The Dexcom CEO will lead the lobbying group’s sector representing diabetes tech companies around the world.
By Elise Reuter • Feb. 24, 2026 -
Medtronic’s MiniMed prices IPO at up to $784M
The diabetes spinoff plans to offer 28 million shares at $25 to $28 each.
By Elise Reuter • Feb. 24, 2026 -
Trump tariffs
AdvaMed urges tailored tariff approach for medtech
CEO Scott Whitaker said the medtech lobbying group stands ready to work with President Donald Trump to address trade imbalances by confronting unfair foreign practices in the sector.
By Susan Kelly • Feb. 24, 2026 -
Medtronic to cut 81 employees at California diabetes site
As Medtronic prepares to spin out its diabetes business, a spokesperson said the company is considering the structure, capabilities and scale needed to succeed.
By Elise Reuter • Feb. 20, 2026 -
Medtronic’s blood pressure device wins coverage nod in Japan
Medtronic is investing in the rollout of the Symplicity Spyral renal denervation procedure, including hiring for new market development roles, CEO Geoff Martha said on an earnings call.
By Susan Kelly • Feb. 20, 2026 -
Senseonics launches automated insulin dosing system with 1-year CGM
The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes.
By Nick Paul Taylor • Feb. 20, 2026 -
FDA issues early alert on Trividia glucometer issue linked to 114 injuries
Users may receive an error code either due to a test strip error or a very high blood glucose event, Trividia Health said.
By Elise Reuter • Feb. 19, 2026 -
Apple Watch’s hypertension feature may miss some cases, researchers find
The absence of an alert provides limited reassurance, particularly for older adults or people with an elevated risk of high blood pressure, according to the study’s authors.
By Elise Reuter • Feb. 19, 2026 -
Medline addresses bed fire risk linked to death
The FDA said hand pendants and cords may overheat, causing the devices to spark, burn, melt, smoke and catch fire.
By Nick Paul Taylor • Feb. 18, 2026 -
Medtronic nets FDA clearance for robotic spine system
Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes market share in the $15 billion cranial and spinal technologies sector.
By Susan Kelly • Feb. 18, 2026 -
Danaher to buy Masimo for $9.9B to boost diagnostics portfolio
Masimo’s board considered other potential partners before determining Danaher was an “ideal fit,” executives at the patient monitoring company said.
By Susan Kelly • Feb. 17, 2026 -
Dexcom seeks expanded Medicare coverage of CGMs for Type 2 diabetes
New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.
By Elise Reuter • Feb. 13, 2026 -
Siemens Healthineers, Mayo Clinic partner on neurodegenerative disease, cancer
An expanded collaboration between the two organizations will focus on prostate cancer and metastatic liver tumors, in addition to certain neurological disorders.
By Susan Kelly • Feb. 13, 2026